P53 POLYMORPHISMS AND HAPLOTYPES IN DIFFERENT ETHNIC-GROUPS

被引：130

作者：

SJALANDER, A

BIRGANDER, R

KIVELA, A

BECKMAN, G

机构：

[1] UMEA UNIV,DEPT MED GENET,S-90185 UMEA,SWEDEN

[2] UNIV OULU,DEPT OBSTET & GYNECOL,SF-90220 OULU,FINLAND

来源：

HUMAN HEREDITY | 1995年 / 45卷 / 03期

关键词：

DNA POLYMORPHISM; EXTENDED HAPLOTYPES; ETHNIC HETEROGENEITY; LINKAGE DISEQUILIBRIUM; P53;

D O I：

10.1159/000154275

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Three different p53 polymorphisms (a codon 72 BstUI RFLP, a 16-bp duplication in intron 3 and an MspI RFLP in intron 6) and haplotype combinations were studied in three northern European populations, viz. Finns, Swedes and Swedish Saamis. Significant ethnic differences were found in the codon 72 and 16-bp polymorphisms. The three polymorphisms were in strong linkage disequilibria, all of which were highly significant (p < 1 x 10(-18)), and ethnic differences with respect to linkage disequilibria were observed. Estimates of the frequencies of extended haplotypes showed that the most common ('wild-type') haplotype in the three populations was 2-1-2, viz, the codon 72 Arg allele linked to absence of the 16-bp duplication and presence of the MspI site. There were two additional common haplotypes, 1-1-2 and 1-2-1, and five rare haplotypes with a combined frequency of about 0.03. The present results indicate that extended haplotypes would be more informative in studies of population differences and associations between p53 germline mutations and cancer.

引用

页码：144 / 149

页数：6

共 22 条

[1] Levine A.J., Momand J., Finlay C.A., The p53 tumour suppressor gene, Nature, 351, pp. 453-456, (1991)
[2] El-Deiry W.S., Kern S.E., Pietenpol J.A., Kinzler K.W., Vogelstein B., Definition of a consensus binding site for p53, Nat Genet, 1, pp. 45-49, (1992)
[3] Harris C.C., p53: At the crossroad of molecular carcinogenesis and risk assessment, Science, 262, pp. 1980-1981, (1993)
[4] Chang F., Syrjanen S., Kurvinen K., Syrjanen K., The p53 tumor suppressor gene as a common cellular target in human carcinogenesis, Am J Gastroenterol, 88, pp. 174-186, (1993)
[5] Clarke A.R., Purdie C.A., Harrison D.J., Morris R.G., Bird C.C., Hooper M.L., Wyllie A.H., Thymocyte apopto- Sis induced by p53-dependent and independent pathways, Nature, 362, pp. 849-852, (1993)
[6] Law J.C., Strong L.C., Chidambaram A., Ferrell R.E., Germ line mutaion in exon 5 of the p53 gene in an extended cancer family, Cancer Res, 51, pp. 6385-6387, (1991)
[7] Kawajiri K., Nakachi K., Imai K., Watanabe J., Hayashi S.I., Germ line polymorphism of p53 and CYP1A1 genes involved in human lung cancer, Carcinogenesis, 14, pp. 1085-1089, (1993)
[8] Buchman V.L., Chumakov P.M., Nin-Kina N.N., Samarina O.P., Georgiev G.P., A variation in the structure of (he protein-coding region of the human p53 gene, Gene, 70, pp. 245-252, (1988)
[9] de la Calle-Martin O., Romero M., Fabregat V., Ercilla G., Vives J., Ya-gue J., Mspl polymorphism of the human p53 gene, Nucleic Acids Res, 18, pp. 49-63, (1990)
[10] Carbone D., Chiba I., Mitsudomi T., Polymorphism at codon 213 within the p53 gene, Oncogene, 6, pp. 1691-1692, (1991)

← 1 2 3 →